Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713735 · ClinicalTrials.gov registry record · NA
Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT04713735 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 76 participants.
The verdict
NCT04713735, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.
Interventions
- DIETARY_SUPPLEMENT bovine lactoferrin supplement
- DIETARY_SUPPLEMENT Control: Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2023-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713735
The ClinicalTrials.gov registry entry for NCT04713735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mead Johnson Nutrition, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bovine lactoferrin supplement is the first listed.
NCT04713735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04713735 about?
NCT04713735 is a clinical study titled "Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections". This is a randomized, double-blind, placebo-controlled study to evaluate the impact of bovine Lactoferrin (bLf) on respiratory tract infections (RTIs) in an elderly population in the United States.
What is the current status of trial NCT04713735?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2021-02-08. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04713735?
The interventions under investigation include: bovine lactoferrin supplement (DIETARY_SUPPLEMENT), Control: Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04713735?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.